【レポートの概要（一部）】
1. Analyst View
2. Research Methodology
3. Global Cancer Drugs Market Outlook 2018
3.1 Cancer Incidences
3.2 Cancer Drug Market
4. Global Cancer Generics Market Analysis 2018
5. Cancer Generic Drugs Industry
5.1 Oral Generic Drugs
5.1.1 Arimidex (Anastrozole)
5.1.2 Femara (Letrozole)
5.1.3 Hycamtin (Topotecan)
5.1.4 Stivarga (Regorafenib)
5.1.5 Tarceva (Erlotinib)
5.1.6 Xalkori (Crizotinib)
5.1.7 Xeloda (Capecitabine)
5.2 Generic Injectables
5.2.1 Camptosar (Irinotecan Hydrochloride)
5.2.2 Eloxatin (Oxaliplatin)
5.2.3 Gemzar (Gemcitabine Hydrochloride)
5.2.4 Navelbine (Vinorelbine Tartrate)
5.2.5 Platinol (Cisplatin)
5.2.6 Taxol (Paclitaxel)
5.2.7 Taxotere (Docetaxel)
6. Cancer Generics Market: Major Indications
6.1 Lung Cancer
6.1.1 Incidence Outlook
6.1.2 Commercialized Drugs
6.2 Breast Cancer
6.2.1 Incidence Outlook
6.2.2 Commercialized Drugs
6.3 Colorectal Cancer
6.3.1 Incidence Outlook
6.3.2 Commercialized Drugs
6.4 Stomach Cancer
6.4.1 Incidence Outlook
6.4.2 Commercialized Drugs
6.5 Prostate Cancer
6.5.1 Incidence Outlook
6.5.2 Commercialized Drugs
7. Market Dynamics
7.1 Indian Generic Cancer Drug Introduced in the US Market
7.2 Launch of Generic Drugs for Oncology
7.3 Increasing Cancer Burden Paving Way for Generics
7.4 Patent Expiry of Blockbuster Oncology Drugs
7.5 Strategic Collaborations
8. Key Players
8.1 Fresenius Kabi AG
8.1.1 Business Overview
8.1.2 Key Financials
8.1.3 Strategic Developments
8.2 Actavis Plc.
8.2.1 Business Overview
8.2.2 Key Financials
8.2.3 Strategic Developments
8.3 Hospira
8.3.1 Business Overview
8.3.2 Key Financials
8.3.3 Strategic Developments
8.4 Teva Pharmaceutical Industries Ltd.
8.4.1 Business Overview
8.4.2 Key Financials
8.4.3 Strategic Developments
8.5 Mylan
8.5.1 Business Overview
8.5.2 Key Financials
8.5.3 Strategic Developments
8.6 Sun Pharmaceuticals
8.6.1 Business Overview
8.6.2 Key Financials
8.6.3 Strategic Developments
List of Figures:
Figure 3-1: Global – Number of New Cancer Cases (Million), 2012 & 2025
Figure 3-2: Global – Cancer Incidences by Gender (Million), 2012
Figure 3-3: Global – Cancer Drugs Market (Billion US$), 2008-2013
Figure 3-4: Global – Cancer Drugs Market (Billion US$), 2014-2018
Figure 3-5: Cancer Drugs Market Share by Geography (%), 2013
Figure 3-6: Cancer Drugs Market Share by Geography (%), 2018
Figure 3-7: Global – Cancer Treatment Modalities Revenue Share (%), 2013
Figure 4-1: Global – Cancer Generics Market (Billion US$), 2013-2018
Figure 6-1: Global – Number of New Lung Cancer Cases (Million), 2012 & 2020
Figure 6-2: Global – Forecast for New Lung Cancer Cases by Region (%), 2020
Figure 6-3: Global – Number of New Breast Cancer Cases (Million), 2012 & 2020
Figure 6-4: Global – Forecast for New Breast Cancer Cases by Region (%), 2020
Figure 6-5: Global – Number of New Colorectal Cancer Cases (Million), 2012 & 2020
Figure 6-6: Global – Forecast for New Colorectal Cancer Cases by Region (%), 2020
Figure 6-7: Global – Number of New Stomach Cancer Cases (Million), 2012 & 2020
Figure 6-8: Global – Forecast for New Stomach Cancer Cases by Region (%), 2020
Figure 6-9: Global – Number of New Prostate Cancer Cases (Million), 2012 & 2020
Figure 6-10: Global – Forecast for New Prostate Cancer Cases by Region (%), 2020
Figure 8-1: Fresenius Kabi – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-2: Fresenius Kabi – Revenue Share by Region (%), 2013
Figure 8-3: Fresenius Kabi – Revenue Share by Business Segment (%), 2013
Figure 8-4: Actavis – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-5: Actavis – Revenue Share by Region (%), 2013
Figure 8-6: Actavis – Revenue Share by Business Segment (%), 2013
Figure 8-7: Hospira – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-8: Hospira – Revenue Share by Region (%), 2013
Figure 8-9: Hospira – Revenue Share by Business Segment (%), 2013
Figure 8-10: Teva – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-11: Teva – Revenue Share by Region (%), 2013
Figure 8-12: Hospira – Revenue Share by Business Segment (%), 2013
Figure 8-13: Mylan – Sales & Net Income (Billion US$), 2012 & 2013
Figure 8-14: Mylan – Revenue Share by Region (%), 2013
Figure 8-15: Mylan – Revenue Share by Business Segment (%), 2013
Figure 8-16: Sun Pharma – Sales & Net Income (Billion US$), 2012-13/ 2013-14
Figure 8-17: Sun Pharma – Revenue Share by Business Segment (%), 2013-14
List of Tables:
Table 3-1: Most Prevalent Types of Cancer
Table 3-2: Top 10 Countries with Highest Cancer Prevalence Rates
Table 5-1: List of Companies Dealing in Generic Arimidex
Table 5-2: Cost Comparison of Generics and Branded Arimidex (Anastrozole)
Table 5-3: List of Companies Dealing in Generic Femara
Table 5-4: Cost Comparison of Generics and Branded Femara (Letrozole)
Table 5-5: List of Companies Dealing in Generic Hycamtin
Table 5-6: List of Companies Dealing in Generic Xeloda
Table 5-7: Cost Comparison of Generics and Branded Xeloda (Capecitabine)
Table 5-8: List of Companies Dealing in Generic Camptosar
Table 5-9: Cost Comparison of Generics and Branded Camptosar (Irinotecan Hydrochloride)
Table 5-10: List of Companies Dealing in Generic Gemzar (Gemcitabine Hydrochloride)
Table 5-11: Cost Comparison of Generics and Branded Gemzar (Gemcitabine Hydrochloride)
Table 5-12: List of Companies Dealing in Generic Navelbine (Vinorelbine)
Table 5-13: Cost Comparison of Generics and Branded Navelbine (Vinorelbine)
Table 5-14: List of Companies Dealing in Generic Platinol (Cisplatin)
Table 5-15: List of Companies Dealing in Generic Taxol (Paclitaxel)
Table 5-16: Cost Comparison of Generics and Branded Taxol (Paclitaxel)
Table 5-17: List of Companies Dealing in Generic Taxotere (Docetaxel)
Table 5-18: Cost Comparison of Generics and Branded Taxotere (Docetaxel)
Table 6-1: Top 10 Countries by Lung Cancer Incidences (2012)
Table 6-2: Global – Key Lung Cancer Drugs and Patent Expiry Status
Table 6-3: Top 10 Countries by Breast Cancer Incidences (2012)
Table 6-4: Global – Key Breast Cancer Drugs and Patent Expiry Status
Table 6-5: Top 10 Countries by Colorectal Cancer Incidences (2012)
Table 6-6: Global – Key Colorectal Cancer Drugs and Patent Expiry Status
Table 6-7: Top 10 Countries by Stomach Cancer Incidences (2012)
Table 6-8: Global – Key Stomach Cancer Drugs and Patent Expiry Status
Table 6-9: Top 10 Countries by Prostate Cancer Incidences (2012)
Table 6-10: Global – Key Prostate Cancer Drugs and Patent Expiry Status
Table 7-1: Global – Key Cancer Drugs and Patent Expiry Status
Table 8-1: Fresnius Kabi Pharmaceuticals – Key Cancer Generic Drugs
Table 8-2: Actavis – Key Cancer Generic Drugs
Table 8-3: Hospira – Key Cancer Generic Products
Table 8-4: Teva Pharmaceuticals – Key Cancer Generic Drugs
Table 8-5: Mylan – Key Cancer Generic Drugs
Table 8-6: Sun Pharmaceuticals – Key Cancer Generic Drugs
【レポート販売概要】
■ タイトル：世界の癌治療用ジェネリック医薬品市場■ 英文：Global Cancer Generics Market Outlook 2018
■ 発行日：2014年8月
■ 調査会社：RNCOS
■ 商品コード：RNCS4087
■ 調査対象地域：グローバル
- ホットメルト接着剤の世界市場2016-2020About the Hot Melt Adhesives Market Hot melt adhesives are solvent-free thermoplastic materials. They are molten at temperatures ranging from 248°F to 356°F and used as an adhesive. Unlike solvent-based or water-based adhesives, these adhesives do not require curing or drying. They solidify in a short time span and form a strong bond with an extensive range of substrates. Technavio’s analysts fore …
- スペインの気道装置・麻酔装置市場Spain Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "Spain Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the Spain Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Circuits, Anesthesia Masks, Ai …
- 浮体式生産システムのグローバル市場動向（～2018）This report estimates the floating production systems market in terms of volume and value. The volume market is estimated in terms of number of orders booked per year and value in terms of contract value. This has been broken down into component regions and is further split into countries. Floating production systems are required for oil and gas development. The ever-increasing offshore exploratio …
- やし油の世界市場Coconut oil (CAS 8001-31-8) Market Research Report 2013 presents comprehensive data on coconut oil markets globally and regionally (Europe, Asia, North America etc.) The Coconut oil (CAS 8001-31-8) Market Research Report 2013 includes coconut oil description, covers its application areas and related patterns. It overviews coconut oil market, names coconut oil producers and indicates its suppliers. …
- HPV検査の世界市場2016-2020About HPV Testing According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other type …
- 世界のメチルエチルケトン(MEK)市場2015The Global Methyl Ethyl Ketone (MEK) Industry Report 2015 is a professional and in-depth study on the current state of the Methyl Ethyl Ketone (MEK) industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Methyl Ethyl Ketone (MEK) market analysis is provided for the international markets including developm …
- 大動脈瘤(Aortic Aneurysm)：世界の治験レビュー（2015年上半期版）Aortic Aneurysm Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Aortic Aneurysm Global Clinical Trials Review, H1, 2015" provides data on the Aortic Aneurysm clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aortic Aneurysm. It includes an overview of the trial numbers and their recruitment status as …
- プリント基板用コネクタの世界市場2017-2021About Printed Circuit Board ConnectorsA printed circuit board connector, or PCB connector, includes housing and a certain number of terminals to connect electronic components, which contain a conductive pattern printed on the surface of the insulating base, with each terminal on a PCB connector connected to a PCB. Technavio’s analysts forecast the global printed circuit board connectors market to …
- Novolog (Type 2 Diabetes)：市場予測と分析（～2022）Novolog (Type 2 Diabetes) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new report, “Novolog (Type 2 Diabetes) - Forecast and Market Analysis to 2022”. The type 2 diabetes market is mature and crowded with inexpensive generics. Despite being marked by a late-stage pipeline filled with me-too drugs, this market will undergo substantial growth between 2012 and 2022, more …
- リチウムイオン電池用バインダーの世界市場2019-2023Global Binder Market for Lithium-ion Batteries: About this market Technavio’s binder market for lithium-ion batteries market analysis considers sales from both cathode binders and anode binders. Our analysis also considers the sales of binder market for lithium-ion batteries in APAC, Europe, North America, South America, and MEA. In 2018, the cathode binders segment had a significant market share, …
- 殺鼠剤（ねずみ駆除剤）のグローバル市場Report Description The rodenticides market size is projected to increase due to the demand for food grains and rising farmers concerns over food wastage due to rodents. Rodenticides are also used in integrated pest management programs. The emerging markets with increasing demand for rodenticides are estimated to generate potential opportunities in the market. The rodenticides market was sub-segmen …
- Ziemer Ophthalmic Systems AG：市場シェア分析Ziemer Ophthalmic Systems AG Market Share Analysis Summary GlobalData’s new report, “Ziemer Ophthalmic Systems AG Market Share Analysis” provides in-depth information on Ziemer Ophthalmic Systems AG’s market position in the different medical equipment markets it operates in. The report provides Ziemer Ophthalmic Systems AG market share information in two key market categories – Ophthalmic Diagnost …
- 電気自動車モータコントローラの世界市場2017-2021About Electric Vehicle Motor ControllersAn electric vehicle (EV) motor controller is a device that is used to control the torque produced by electric motors by regulating the energy flow between the motor and power sources. Technavio’s analysts forecast the global electric vehicle motor controllers market to grow at a CAGR of 42.51% during the period 2017-2021. [Covered in this report] The report …
- Respiratory Diseases in Spain 2014: Market Outlook and Emerging OpportunitiesAbout This ReportThis new 281-page report from Venture Planning Group presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals and Commercial/Private Labs. …
- 自動力率制御装置（APFC）の世界市場予測（～2022年）：リレー、コンデンサ、ディスプレイ、マイクロコントローラ、スイッチ、レジスターThe global automatic power factor controller market is estimated to grow at a CAGR of 4.6% and is expected to be valued at USD 4.78 Billion by 2022. APFCs help in lower the power consumption due to the presence of non-linear loads such as transformers, motors, and other machines in industries. Also, the growing demand for APFCs in the utility and manufacturing industries to improve the reactive po …
